Study suggests texture analysis can help distinguish benign from malignant adrenal nodules

October 31, 2019 | Radiomics

A recent study published in the American Journal of Roentgenology suggests use of texture analysis for evaluation of adrenal nodules can play a role in distinguishing benign from adrenal malignancy, decreasing the need for additional imaging studies. The researchers showed that contrast-enhanced computerized tomography (CECT) texture features were most predictive of malignancy.

Given the relatively frequent occurrence of incidental adrenal nodules, using CECT to reliably differentiate benign from malignant adrenal nodules on the initial discovery examination would be more efficient, alleviating the need for some patients to undergo additional imaging. Not only would this save time and costs; it could potentially help the right patients start treatment earlier, improving outcomes.

The HealthMyne® Platform allows clinicians to extract radiomic features such as  texture in the standard clinical workflow. Clinicians can receive notifications when nodules and lesions  match certain features or signatures, helping them personalize diagnoses. To read the full publication, click here. To learn more about HealthMyne, schedule a personalized demo here.